Bisphosphonates: from softening water to treating PXE.
作者信息
Moore Stephanie N, Tanner S Bobo, Schoenecker Jonathan G
机构信息
a Department of Orthopaedics ; Vanderbilt University Medical Center ; Nashville , TN USA.
出版信息
Cell Cycle. 2015;14(9):1354-5. doi: 10.1080/15384101.2015.1024585.
Abstract
摘要
相似文献
1
Bisphosphonates: from softening water to treating PXE.
Cell Cycle. 2015;14(9):1354-5. doi: 10.1080/15384101.2015.1024585.
2
The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene.
Cell Cycle. 2015;14(7):1082-9. doi: 10.1080/15384101.2015.1007809.
3
Zebrafish enpp1 mutants exhibit pathological mineralization, mimicking features of generalized arterial calcification of infancy (GACI) and pseudoxanthoma elasticum (PXE).
Dis Model Mech. 2014 Jul;7(7):811-22. doi: 10.1242/dmm.015693. Epub 2014 Jun 6.
4
Oral administration of pyrophosphate inhibits connective tissue calcification.
EMBO Mol Med. 2017 Nov;9(11):1463-1470. doi: 10.15252/emmm.201707532.
5
Etidronate for Prevention of Ectopic Mineralization in Patients With Pseudoxanthoma Elasticum.
J Am Coll Cardiol. 2018 Mar 13;71(10):1117-1126. doi: 10.1016/j.jacc.2017.12.062.
6
Inhibition of Tissue-Nonspecific Alkaline Phosphatase Attenuates Ectopic Mineralization in the Abcc6 Mouse Model of PXE but Not in the Enpp1 Mutant Mouse Models of GACI.
J Invest Dermatol. 2019 Feb;139(2):360-368. doi: 10.1016/j.jid.2018.07.030. Epub 2018 Aug 18.
7
ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.
Int J Mol Sci. 2021 Apr 27;22(9):4555. doi: 10.3390/ijms22094555.
8
Oral supplementation of inorganic pyrophosphate in pseudoxanthoma elasticum.
Exp Dermatol. 2022 Apr;31(4):548-555. doi: 10.1111/exd.14498. Epub 2021 Nov 17.
9
Reversion of arterial calcification by elastin-targeted DTPA-HSA nanoparticles.
Eur J Pharm Biopharm. 2020 May;150:108-119. doi: 10.1016/j.ejpb.2020.03.007. Epub 2020 Mar 6.
10
Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6.
Am J Hum Genet. 2012 Jan 13;90(1):25-39. doi: 10.1016/j.ajhg.2011.11.020. Epub 2011 Dec 29.
引用本文的文献
1
The Abcc6a Knockout Zebrafish Model as a Novel Tool for Drug Screening for Pseudoxanthoma Elasticum.
Front Pharmacol. 2022 Mar 4;13:822143. doi: 10.3389/fphar.2022.822143. eCollection 2022.
2
Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repair.
Osteoporos Int. 2022 Apr;33(4):807-820. doi: 10.1007/s00198-021-06208-7. Epub 2021 Oct 31.
3
Severe injury-induced osteoporosis and skeletal muscle mineralization: Are these related complications?
Bone Rep. 2020 Dec 26;14:100743. doi: 10.1016/j.bonr.2020.100743. eCollection 2021 Jun.
4
Trauma-Induced Nanohydroxyapatite Deposition in Skeletal Muscle is Sufficient to Drive Heterotopic Ossification.
Calcif Tissue Int. 2019 Apr;104(4):411-425. doi: 10.1007/s00223-018-0502-5. Epub 2018 Dec 4.
本文引用的文献
1
Mineral content of the maternal diet influences ectopic mineralization in offspring of Abcc6(-/-) mice.
Cell Cycle. 2015;14(19):3184-9. doi: 10.1080/15384101.2015.1068473.
2
PSEUDOXANTHOMA ELASTICUM: DIAGNOSTIC FEATURES, CLASSIFICATION, AND TREATMENT OPTIONS.
Expert Opin Orphan Drugs. 2014 Jun 1;2(6):567-577. doi: 10.1517/21678707.2014.908702.
3
The use of bisphosphonates in pediatrics.
Horm Res Paediatr. 2014;82(5):290-302. doi: 10.1159/000365889. Epub 2014 Nov 6.
4
Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum.
J Dermatol Sci. 2014 Aug;75(2):109-20. doi: 10.1016/j.jdermsci.2014.04.015. Epub 2014 May 17.
5
Pleiotropic effects of bisphosphonates on osteosarcoma.
Bone. 2014 Jun;63:110-20. doi: 10.1016/j.bone.2014.03.005. Epub 2014 Mar 14.
6
Bisphosphonates: the first 40 years.
Bone. 2011 Jul;49(1):2-19. doi: 10.1016/j.bone.2011.04.022. Epub 2011 May 1.
7
Safety of bisphosphonates.
Bone. 2011 Jul;49(1):103-10. doi: 10.1016/j.bone.2011.01.003. Epub 2011 Jan 12.
Zotero 插件